Sandoz Recalls Aprepitant Capsules and Lidocaine and Prilocaine Cream Prescription Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning
The recalled prescription drugs and products that contain lidocaine must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
Related posts:
Cannondale Recalls Tesoro Neo X Speed Electric Bicycles Due to Fall and Injury Hazards
March 29, 2023Monoprice Recalls Pure Outdoor Cooking System Due to Fire Hazard (Recall Alert)
March 8, 2023Lil Anglers Recalls Children's Fishing Rods Sold with Kid Casters No Tangle Combos Due to Violation ...
April 19, 2023Views: 304